Ajiki T, Onoyama H, Yamamoto M, Fujimori T, Maeda S, Saitoh Y
First Department of Surgery, Kobe University School of Medicine, Kobe, Japan.
Int J Pancreatol. 1995 Dec;18(3):215-20. doi: 10.1007/BF02784944.
Detection of K-ras mutations at codon 12 constitutes one modality for diagnosis of pancreatic tumors. We attempted to detect K-ras mutations in DNA from bile collected through percutaneous transhepatic choledochal drainage (PTCD) tubes as a diagnostic approach to biliary strictures. Since bile salts induce cell damage, we first investigated the degeneration of cells according to bile exposure time using cell lines. High-mol-wt DNA could be extracted from cells exposed to bile for 6 h, but not from those exposed for 12 h. However, DNA exposed to bile for up 12 h could be amplified by the polymerase chain reaction (PCR) method. Therefore, K-ras mutations in fresh bile specimens collected from 15 patients through PTCD tubes were examined using PCR with restriction enzyme digestion. K-ras mutations were found in five out of five (100%) pancreatic cancers, all of which were negative according to cytodiagnosis of the same bile. On the other hand, K-ras mutations were not detected in bile from biliary tract cancers or metastatic neoplasms, except for one bile duct carcinoma and one metastatic case. Thus, although K-ras mutation alone is not an absolute marker for cancer, detection of K-ras mutations in fresh bile from PTCD tubes is a useful adjunct for diagnosis of pancreatic carcinomas in cases of biliary tract strictures.
检测密码子12处的K-ras突变是诊断胰腺肿瘤的一种方法。我们试图检测经皮经肝胆道引流(PTCD)管收集的胆汁DNA中的K-ras突变,作为胆道狭窄的诊断方法。由于胆汁盐会导致细胞损伤,我们首先使用细胞系根据胆汁暴露时间研究细胞的变性。暴露于胆汁6小时的细胞可以提取高分子量DNA,但暴露12小时的细胞则不能。然而,暴露于胆汁长达12小时的DNA可以通过聚合酶链反应(PCR)方法进行扩增。因此,使用PCR和限制性内切酶消化检测了通过PTCD管从15例患者收集的新鲜胆汁标本中的K-ras突变。在5例胰腺癌患者中,有5例(100%)检测到K-ras突变,而相同胆汁的细胞诊断均为阴性。另一方面,除1例胆管癌和1例转移病例外,在胆道癌或转移性肿瘤的胆汁中未检测到K-ras突变。因此,虽然单独的K-ras突变不是癌症的绝对标志物,但在PTCD管收集的新鲜胆汁中检测K-ras突变对于胆道狭窄病例中胰腺癌的诊断是一种有用的辅助手段。